Mingo M. H. Yung

SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells

Xuan Yang, Huogang Wang, Mingo M. H. Yung et al. · Theranostics · 2022 · 251 citations · Full text

Medicine, Cancer Biology, Oncology +17

MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

Celia S. L. Mak, Mingo M. H. Yung, Lynn Hui et al. · Molecular Cancer · 2017 · 155 citations · Full text

Medicine, Molecular Biology, Oncology +17

RETRACTED ARTICLE: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

Jing Sun, Xin Cai, Mingo M. H. Yung et al. · Oncogene · 2018 · 142 citations · Full text

Medicine, Molecular Biology, Oncology +16

MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis

David W. Chan, Mingo M. H. Yung, Yau-Sang Chan et al. · Pharmacological Research · 2020 · 125 citations · Full text

Medicine, Oncology, Pharmacology +14

Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade

Mingo M. H. Yung, David W. Chan, Vincent Wing Sun Liu et al. · BMC Cancer · 2013 · 112 citations · Full text

Medicine, Cell Biology, Oncology +15